AAlchemy Ventures
AAlchemy Growth Lab by AAlchemy Ventures is a next-generation early-stage startup acceleration platform created by professional angel investors, coaches and mentors.
Our mission is to guide early-stage startups from vision to investment, equipping founders with the tools, knowledge, and connections to secure their first funding round.
We help with registering European company and opening bank account, obtaining "startup visas" or work permissions for the core team, arranging grant and equity financing, helping with hiring, providing access to potential buyers and customers, and much more.
Aarin Capital
Aarin Capital is a proprietary venture fund that invests in technology-intensive businesses in life-sciences, healthcare, education and other potentially large India-centric or India-first market opportunities.
We seek to create long-term value by partnering with knowledgeable, adept and passionate founder teams who aim to transform business leveraging technology. We complement their zeal with our experience to facilitate the journey to build large valuable enterprises. Technology and differentiation are key to the businesses that we invest in. We aim to fund companies that seek to build sustainable and profitable value propositions right from their inception.
Our support typically includes providing strategic advice and extending our networks to investees relating to:
- Validating strategy and developing a customer-centric focus
- Assisting profitable growth – increasing revenue while optimizing costs
- Facilitating scalability across geographies
- Optimizing free cash-flows
- Bolstering governance and compliance
Aarin also invests in entrepreneurial fund managers with investment theses that complement Aarin’s investment areas in terms of sectors and stages at which they engage with founders. The objective is to create and nurture an expansive platform of investment opportunities that broaden the access into the Indian start-up ecosystem.
Aarohan Ventures
Aarohan Ventures is an incubator and venture capital firm specializing in seed and early stage investments. The firm typically invests in education, healthcare, technology for impact, and livelihood sectors.
Aavishkaar Capital
Aavishkaar started in the year 2001 with a vision to invest in entrepreneurs building sustainable enterprises that can catalyze development impact for excluded communities and remote geographies across the globe. Aavishkaar's initial focus was India and now is taking its learnings to countries in South and South East Asia.
Over the years, Aavishkaar through its various initiatives in micro equity and micro finance space has pioneered the approach of building a financial ecosystem that would nurture entrepreneurs by providing risk capital for scalable rural focused enterprises. Our mission is to evolve an approach to investing that nurture entrepreneurs in building enterprises that can generate commercial returns while serving humanity sustainably.
AB Max Sievert
AB Max Sievert is a long-term corporate owner of profitable companies based in Stockholm, Sweden. Originally founded in 1882, the firm was restarted in 2014 under the leadership of Christian Sievert, who previously spent 17 years at private equity firm Segulah. The team comprises five permanent employees, a board, and several active co-owners involved in the ownership functions of their portfolio companies. AB Max Sievert is distinguished by its combination of historical roots and contemporary strategic ownership in a broad range of industries.
AB Max Sievert invests in a variety of sectors, focusing primarily on established, profitable, and internationally expanding companies. They act primarily as a private equity firm. The firm does not limit its geographic focus but seeks companies with significant growth prospects. They have not disclosed specific check sizes or total AUM. Investors and stakeholders include significant owners and active co-owners.
Notable investments by AB Max Sievert include companies growing internationally in diverse industries. Specific company names were not mentioned, reflecting their focus on broader industry investments rather than highlighting individual entities. This reflects a strategy centered on sustainable growth and operational excellence across their portfolio.
AB Ventures
AB Ventures is a Corporate Venture Capital firm based in Jordan, established in 2018 as part of Arab Bank's Digital Innovation Strategy. The firm serves as the independent venture capital arm of Arab Bank, which has a significant presence in the Middle East and internationally. AB Ventures focuses on digital innovation, particularly in fintech, and aims to integrate cutting-edge financial solutions into various markets. The team consists of seasoned venture capital professionals with experience in bridging traditional financial institutions with innovative fintech ventures.
The firm invests globally in early-stage scalable fintech companies, covering both consumer-facing and enterprise-focused business models. AB Ventures seeks companies that build proprietary products demonstrating network effects across the financial industry verticals. They invest in enabling technologies for multiple industries, such as intelligent algorithms, big data, cloud computing, and AI, and facilitate the onset of decentralized technology backbones. The fund is evergreen, continually investing to keep up with digital transformation trends.
Some of AB Ventures' notable investments include Token.io, M10, Commuter Club, PXL Vision, Nord Investments, Factris, Veem, Axe Trading, Hyperpay, Swoop, Invygo, and Lendo. These companies operate in areas like payment processing, trading technology, verification services, and other fintech-empowered business models.
Abac Capital
Abac Capital is a leading Spanish investment firm with deep private equity roots and the purpose of investing with impact. The founding partners bring a strong track record of financial and operational excellence partnering with successful entrepreneurs and management teams and has more than 100 years of experience in private equity and venture capital. The team’s track record covers a wide range of sectors, countries, development phases and both equity and debt instruments.
Abac Capital is a certified B Corp entity, proof of its commitment to sustainability. With the Abac Fast Forward team, it helps the companies in its portfolio to become more digital, more international and to incorporate sustainability into its purpose.
Abac's Private Equity funds invest in solid, cash flow positive businesses led by great teams that face transformational challenges or need liquidity and advice to fund their growth. We leverage our strong network of Fast Forward Operating Partners to transform businesses with a hands-on management approach, delivering long-term, sustainable returns.
Our Venture Capital practice, Abac Nest, invests in seed-stage companies in Spain with global ambitions. Abac Nest was founded in Barcelona in 2017 by the team behind Abac Capital and its network of industry veterans, who have accumulated extensive experience investing in early-stage companies since the 90s. We partner with purpose-led teams with a go-get-it mindset, a sheer passion to create the next big thing, and a mission to redefine industries sustainably. The Fund puts to work its broad operational and sector experience to fuel the growth of next-generation category leaders. At Abac Capital, we think long-term and invest with impact to create value in our businesses and communities. Thus, we put our hearts, heads, and pockets behind the businesses we back, while we share our success with the other stakeholders.
Abakkus Asset Manager
Abakkus Asset Manager Private Limited is an alpha focused asset manager investing in India. Founded in 2018 by Mr Sunil Singhania, we are inspired and have christened our name on the simplest ancient computing instrument – Abacus. Our ambition and vision is to make Abakkus, one of India's most revered and top performing asset managers.
We manage funds on the category III Alternative Investment Fund platform, Portfolio Management Services and RIA with focus on listed Indian equities. Across strategies we manage around Rs 32,000 crs (~USD 4 bn).
ABB Technology Ventures
ABB Technology Ventures (ATV) is the venture capital arm of ABB, a leader in power and automation technologies. Established in 2009 and headquartered in Zurich, Switzerland, ATV focuses on investing in breakthrough technology companies that can benefit from their extensive industry experience. The team is composed of seasoned professionals with a strong track record in technology innovation and commercialization, giving them a distinctive edge in selecting and nurturing cutting-edge technology ventures.
ATV primarily invests in the sectors of industrial automation, robotics, electrification, and digital solutions, which align closely with ABB's overarching strategic goals. They typically target investments at the Series A through late-stage levels globally, with a focus on transformative industrial technologies. Their commitment is reflected in their overall AUM, although specific fund details are not publicly specified.
The portfolio of ABB Technology Ventures includes notable companies such as Enbala - electric grid optimization, Evolv Technology - advanced imaging, and Persimmon Technologies - 3D motors and robotics, demonstrating their strategic emphasis on pioneering industrial and technological solutions.
Abbvie Biotech Ventures
Abbvie Biotech Ventures is a venture capital group based in the United States, founded as part of AbbVie, a prominent pharmaceutical company. The team leverages its extensive industry experience to identify and support promising healthcare innovations across various sub-sectors. The firm prides itself on its commitment to funding potential breakthroughs in biotechnology and advancing new treatments that address significant medical needs. This focus distinguishes them as an investor closely integrated with a global leader in the pharmaceutical sector.
Abbvie Biotech Ventures invests primarily in healthcare sectors, with a focus on immunology, oncology, neuroscience, eye care, and other specialties. They target companies developing novel and innovative therapeutic solutions. Although specific check sizes are not disclosed, their affiliation suggests an ability to engage in substantial funding rounds. Their investments are global, aligning with AbbVie's worldwide operations, but the exact geographic focus for venture investments isn't detailed on their site.
Select investments by this VC arm of Abbvie include early-stage biotech firms working on groundbreaking treatments in areas such as AI and data convergence, precision medicine, and patient-focused drug development, though specific portfolio companies are not explicitly mentioned on their website.